Correlation Between Opus Magnum and Nouveau Life

Can any of the company-specific risk be diversified away by investing in both Opus Magnum and Nouveau Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opus Magnum and Nouveau Life into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Opus Magnum Ameris and Nouveau Life Pharmaceuticals, you can compare the effects of market volatilities on Opus Magnum and Nouveau Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opus Magnum with a short position of Nouveau Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opus Magnum and Nouveau Life.

Diversification Opportunities for Opus Magnum and Nouveau Life

0.0

Correlation Coefficient

Opus Magnum  Nouveau Life

Pay attention - limited upside

The 3 months correlation between Opus and Nouveau is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Opus Magnum Ameris and Nouveau Life Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nouveau Life Pharmac and Opus Magnum is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opus Magnum Ameris are associated (or correlated) with Nouveau Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nouveau Life Pharmac has no effect on the direction of Opus Magnum i.e., Opus Magnum and Nouveau Life go up and down completely randomly.

Pair Corralation between Opus Magnum and Nouveau Life

Given the investment horizon of 90 days Opus Magnum Ameris is expected to under-perform the Nouveau Life. But the pink sheet apears to be less risky and, when comparing its historical volatility, Opus Magnum Ameris is 11.33 times less risky than Nouveau Life. The pink sheet trades about -0.08 of its potential returns per unit of risk. The Nouveau Life Pharmaceuticals is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  0.03  in Nouveau Life Pharmaceuticals on September 12, 2024 and sell it today you would lose (0.03) from holding Nouveau Life Pharmaceuticals or give up 100.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	99.6%
Values	Daily Returns

Opus Magnum Ameris  vs.  Nouveau Life Pharmaceuticals

Opus Magnum Ameris

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Opus Magnum Ameris has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Opus Magnum is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Nouveau Life Pharmac

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Nouveau Life Pharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Nouveau Life showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Opus Magnum and Nouveau Life

The main advantage of trading using opposite Opus Magnum and Nouveau Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opus Magnum position performs unexpectedly, Nouveau Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nouveau Life will offset losses from the drop in Nouveau Life's long position.

The idea behind Opus Magnum Ameris and Nouveau Life Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.